InnoJin is a healthcare technology firm that provides consulting, collecting, analyzing, and offers information on medical services.
InnoJin has raised $3.3M in total funding. The most recent round was Series C. The last funding was announced in July 2026.
InnoJin's investors include Sumitomo, Rohto Pharmaceutical, SEED, Nippon Chemiphar, JINS Holdings.
InnoJin is headquartered in Tokyo, Japan.
InnoJin is a healthcare technology firm that provides consulting, collecting, analyzing, and offers information on medical services.
InnoJin is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"InnoJin — Funding & Investors." VCBacked, July 16, 2026, https://www.vcbacked.co/company/innojin. Accessed August 14, 2026.
VCBacked. (2026). InnoJin — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/innojin
{{cite web |title=InnoJin — Funding & Investors |url=https://www.vcbacked.co/company/innojin |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated